ICCM News and Press, IceCure Medical Ltd. From 11/28/23

2023-11-28 09:39:12 ET More on IceCure Medical IceCure Medical Ltd (ICCM) Q3 2023 Earnings Call Transcript IceCure stock climbs 10% amid FDA appeal, earnings report IceCure Medical 9M GAAP EPS of -$0.26, revenue of $2M Seeking Alpha’s Quant Rating on I...

IceCure System Successfully Treated Kidney Cancer Tumor with 92% Disease-Free Survival Rate and 100% Secondary Local Control Rate PR Newswire Independent study concluded: - IceCure system offers significant advantage in ability to re-treat tumors that are initial...

2023-11-15 14:56:03 ET IceCure Medical Ltd. (ICCM) Q3 2023 Earnings Conference Call November 15, 2023, 10:00 AM ET Company Participants Michael Polyviou - EVC Group, Investor Relations Eyal Shamir - Chief Executive Officer Ronen Tsimerman - Chief Financial Office...

2023-11-15 11:05:05 ET More on IceCure Medical IceCure Medical 9M GAAP EPS of -$0.26, revenue of $2M IceCure stock soars 85% in pre-market trading on positive study results Seeking Alpha’s Quant Rating on IceCure Medical Historical earnings data for Ic...

2023-11-15 08:04:11 ET More on IceCure Medical IceCure stock soars 85% in pre-market trading on positive study results IceCure Medical shares plunge 40% on FDA update Seeking Alpha’s Quant Rating on IceCure Medical Historical earnings data for IceCure ...

IceCure Medical Reports Financial Results as of and for the Nine Months Ended September 30, 2023, and Provides Update on Recent Operational Highlights PR Newswire ProSense® system and disposables sales continue upward trend compared to the equivalent prior year period...

IceCure Medical Files Appeal with U.S. FDA Requesting a Review of its De Novo Classification for ProSense® in Early-Stage Breast Cancer PR Newswire Objective is to reopen file to address comments and find appropriate comparator group that is more representative of the...

The RMR Group Inc. (RMR) is expected to report $0.46 for Q4 2023 Indra Sistemas ADR (ISMAY) is expected to report for Q3 2023 Ceapro Inc. (CRPOF) is expected to report for Q2 2024 Tuya Inc. American Depositary Shares each representing one Class A (TUYA) is expected to report $-0.02 fo...

IceCure Medical Ltd. (ICCM) is expected to report $-0.09 for Q3 2023

IceCure Medical to Report Third Quarter 2023 Financial & Operational Results on November 15, 2023 IceCure Medical to Report Third Quarter 2023 Financial & Operational Results on November 15, 2023 PR Newswire CAESAREA, Israel , Nov. 8, 2023 /PRNewswire...